EUVIMEDSkopri EUVIMED
Open access · CC BY 4.0

Visual, vestibular, and ocular motor changes during nitroglycerin‐triggered vestibular migraine

Maria Dolores Villar-Martinez iD, Francesca Puledda, Caroline Domingos-Belo, Adolfo M Bronstein, Peter J Goadsby

Headache: The Journal of Head and Face Pain · 2026

DOI: 10.1111/head.70194 ↗

At a glance

Journal article in Headache: The Journal of Head and Face Pain, 2026. Written by Maria Dolores Villar-Martinez and 4 co-authors. Institution: NIHR King's Clinical Research Facility, SLaM Biomedical Research Centre and Wolfson Sensory Pain and Regeneration, Institute of Psychiatry, Psycholog…. Major MEDLINE topics: Nitroglycerin, Vestibular Migraine, Nystagmus, Pathologic, Vasodilator Agents. 32 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Institute for Health and Care Research.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background

Intravenous nitroglycerin (NTG) is a well‐established model for provoking migraine attacks, but it has not previously been used to characterize vestibular migraine (VM). Different types of nystagmus have been reported during spontaneous VM attacks. We aimed to measure changes in nystagmus during NTG‐induced migraine in participants with VM.

Methods

We studied 20 participants with definite VM (Barany–International Classification of Headache Disorders, 3rd edition criteria) undergoing NTG provocation in a prospective, within‐subject repeated‐measures pharmacological provocation study under three conditions at the National Institute for Health and Care Research King's Clinical Research Facility, London, between November 2024 to December 2025. Median (interquartile range [IQR]) age was 32 (29 to 38) years, and 16/20 were female. 3D video‐oculography was used to quantify total slow‐phase velocity (SPV) (°/s) of nystagmus without fixation in the center, left, right, up, and down positions. Recordings were repeated before NTG, after NTG, and after subcutaneous sumatriptan. Subjective vestibular symptoms and headache intensity were quantified with an ordinal numeric scale. Longitudinal changes in SPV were analyzed.

Results

All the participants developed headache, with median peak severity 6/10 (IQR 4 to 7). Vestibular symptoms were triggered in 14/20 participants following NTG, with a median maximum intensity of 2.5 (IQR 0 to 4). Median (IQR) summed SPV (°/s) was 2 (1 to 3.25) at baseline, 1.5 (0 to 4.75) following NTG, and 1 (0 to 2.75) after sumatriptan. In Tweedie generalized linear mixed‐effects models, no significant group‐level effect of condition on total SPV was detected. Estimated marginal means were 1.87 (95% confidence interval [CI] 1.02 to 3.41) at baseline, 2.10 (95% CI 1.16 to 3.80) following NTG, and 1.73 (95% CI 0.93 to 3.19) after sumatriptan. Compared with baseline, neither NTG ( β = 0.118, standard error [SE] = 0.267, P = 0.658) nor sumatriptan ( β = −0.078, SE = 0.278, P = 0.780) showed significant effects. NTG provocation was associated with complex perceptions such as visual symptoms (10/20) and Alice in Wonderland syndrome type or dissociative symptoms (6/20), including derealization/depersonalization, metamorphopsia, macropsia and pelopsia, dysmorphopsia, and distorted passage of time.

Conclusions

Quantitative slow phase velocity measures of nystagmus did not show a uniform group‐level change during NTG provocation in VM, despite frequent subjective vestibular symptoms. VM episodes may reflect altered central sensory processing and vestibular hypersensitivity rather than changes in vestibulo‐oculomotor output. image

Subjects

MeSH terms (MEDLINE)

NitroglycerinVestibular MigraineNystagmus, PathologicVasodilator AgentsMigraine DisordersHumansFemaleAdultMaleProspective Studies

Author keywords

Alice in Wonderland syndromeauranitroglycerin provocationnystagmusvestibular migrainevisual symptoms

Substances

NitroglycerinVasodilator Agents

Authors and institutions

  • NIHR King's Clinical Research Facility, SLaM Biomedical Research Centre and Wolfson Sensory Pain and Regeneration, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Department of Brain Sciences, Imperial College, London, UK.
  • University College London Hospitals (NHNN and RNTNE), London, UK.
  • Division of Biomedical Sciences, King Abdullah University of Science and Technology, Thuwal, Saudi Arabia.

ORCID profiles: Maria Dolores Villar-Martinez

Funding

  • National Institute for Health and Care Research

Cite

APA

Villar-Martinez, M. D., Puledda, F., Domingos-Belo, C., Bronstein, A. M., & Goadsby, P. J. (2026). Visual, vestibular, and ocular motor changes during nitroglycerin‐triggered vestibular migraine. Headache: The Journal of Head and Face Pain. https://doi.org/10.1111/head.70194

Vancouver

Villar-Martinez MD, Puledda F, Domingos-Belo C, Bronstein AM, Goadsby PJ. Visual, vestibular, and ocular motor changes during nitroglycerin‐triggered vestibular migraine. Headache: The Journal of Head and Face Pain. 2026. doi:10.1111/head.70194

BibTeX
@article{VillarMartinez2026,
  author = {Villar-Martinez, Maria Dolores and Puledda, Francesca and Domingos-Belo, Caroline and Bronstein, Adolfo M and Goadsby, Peter J},
  title = {Visual, vestibular, and ocular motor changes during nitroglycerin‐triggered vestibular migraine},
  journal = {Headache: The Journal of Head and Face Pain},
  year = {2026},
  doi = {10.1111/head.70194}
}
Start for free →